These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20947846)

  • 1. Anamnestic recall of stroke-related deficits: an animal model.
    Zierath D; Hadwin J; Savos A; Carter KT; Kunze A; Becker KJ
    Stroke; 2010 Nov; 41(11):2653-60. PubMed ID: 20947846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
    Gee JM; Kalil A; Thullbery M; Becker KJ
    Stroke; 2008 May; 39(5):1575-82. PubMed ID: 18323496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.
    Becker KJ; Kindrick DL; Lester MP; Shea C; Ye ZC
    J Cereb Blood Flow Metab; 2005 Dec; 25(12):1634-44. PubMed ID: 15931160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Sympathectomy, but not Adrenergic Blockade, Improves Stroke Outcome.
    Zierath D; Olmstead T; Stults A; Shen A; Kunze A; Becker KJ
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3177-3186. PubMed ID: 30120036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
    Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
    Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS immune responses following experimental stroke.
    Zierath D; Thullbery M; Hadwin J; Gee JM; Savos A; Kalil A; Becker KJ
    Neurocrit Care; 2010 Apr; 12(2):274-84. PubMed ID: 19714497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of antibiotics, pneumonia and the immune response to stroke outcome.
    Becker KJ; Zierath D; Kunze A; Fecteau L; Lee B; Skerrett S
    J Neuroimmunol; 2016 Jun; 295-296():68-74. PubMed ID: 27235351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuity of autoimmune responses to MBP after stroke.
    Zierath D; Kunze A; Fecteau L; Becker K
    J Neuroimmunol; 2015 Aug; 285():101-5. PubMed ID: 26198925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.
    Becker KJ; McCarron RM; Ruetzler C; Laban O; Sternberg E; Flanders KC; Hallenbeck JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10873-8. PubMed ID: 9380727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice.
    Na SY; Mracsko E; Liesz A; Hünig T; Veltkamp R
    Stroke; 2015 Jan; 46(1):212-20. PubMed ID: 25378432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats.
    Rodríguez-Perea AL; Gutierrez-Vargas J; Cardona-Gómez GP; Guarin CJ; Rojas M; Hernández PA
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):152-162. PubMed ID: 27614888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.
    Jin WN; Gonzales R; Feng Y; Wood K; Chai Z; Dong JF; La Cava A; Shi FD; Liu Q
    Stroke; 2018 Jun; 49(6):1471-1478. PubMed ID: 29695462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke.
    Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X
    J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy Does Not Improve Long-Term Outcome After Stroke.
    Zierath D; Shen A; Stults A; Olmstead T; Becker KJ
    Stroke; 2017 Feb; 48(2):497-500. PubMed ID: 28087806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
    Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
    Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
    Gregorian SK; Rostami A
    J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats.
    Becker K; Kindrick D; Relton J; Harlan J; Winn R
    Stroke; 2001 Jan; 32(1):206-11. PubMed ID: 11136938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke.
    Suenaga J; Hu X; Pu H; Shi Y; Hassan SH; Xu M; Leak RK; Stetler RA; Gao Y; Chen J
    Exp Neurol; 2015 Oct; 272():109-19. PubMed ID: 25836044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.
    Savos AV; Gee JM; Zierath D; Becker KJ
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):606-13. PubMed ID: 20700130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation.
    Bodhankar S; Chen Y; Lapato A; Dotson AL; Wang J; Vandenbark AA; Saugstad JA; Offner H
    Stroke; 2015 Oct; 46(10):2926-34. PubMed ID: 26306753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.